A Look at Sheikh Ahmed Dalmook Al Maktoum’s Push to Link Capital with Community Outcomes
The Dubai royal’s investment approach through Inmā Emirates Holdings demonstrates how patient capital and technology...
Editorial
SkylineDx Molecular Test Outperforms Traditional Risk Factors for Melanoma
By Karen Roman SkylineDx said it published new peer-reviewed data where its Merlin CP-GEP Test...
AlphaTON Capital: Capture the Best of Telegram Economics at a Steep Discount – Initiation Report
Download the Complete Report Here By Brandon Hornback Seeking a stock-market bargain to brighten the...
Capital Markets Outlook 2026: ICR Managing Partner Steve Parish, Live at NYSE
IPO Edge hosted a fireside chat on Dec. 9 from the floor of the New...
SOL Strategies: The Premier Public Play on the Solana Economy – Initiation Report
Download the Complete Report Here By Brandon Hornback SOL Strategies Inc. (NASDAQ: STKE) is the...
Vinson & Elkins Advises Coterra Energy on Power Purchase Agreement with PROPWR
By Exec Edge Editorial Staff Vinson & Elkins advised Coterra Energy Inc. on a behind-the-meter...
REX: 21 Profitable Quarters in a Row and Expansion Momentum Ahead — Quarterly Update Report
Download the Complete Report Here By Brandon Hornback REX American Resources Corp. (NYSE: REX) continued...
Sequana Medical Implants 1st FDA-Approved Medical Device For Liver Treatment
By Karen Roman Sequana Medical NV (BRU: SEQUA.BR) said it successfully implanted the alfapump device...
March Biosciences CAR-T Therapy Expectations and Phase 1 Experience
By Daniella Parra March Bio is developing MB-105, a first-in-class autologous CD5-targeted CAR-T cell therapy for...
Beyond WebMD: DxCheck CEO Chris Searles & CTO Trevor Smith, Live at Nasdaq
Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris...
© Copyright 2025, ExecEdge